Related Experiment Video
Updated: Jul 1, 2025
08:20
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
Published on: November 3, 2020
6.3K
Biomaterial engineering strategies for B cell immunity modulations.
Ali Zareein1,2, Mina Mahmoudi1,2, Shruti Sunil Jadhav1
1Department of Biomedical Engineering, Syracuse University, Syracuse, NY, USA. ywu294@syr.edu.
Biomaterials Science
|March 8, 2024
Summary
Biomaterial engineering offers new ways to improve B cell therapies for diseases. These platforms enhance immune responses and overcome limitations of current treatments for better long-term results.
Area of Science:
- Immunology
- Biomaterials Science
- Therapeutics Development
Background:
- B cell immunity is crucial for health and disease, with existing therapies showing success but facing limitations in long-lasting responses.
- Recent advances in understanding B cell biology reveal regulatory networks for differentiation and antibody production.
- Biomaterial platforms are emerging to enhance therapeutic humoral immunity by optimizing immune cell interactions and the microenvironment.
Purpose of the Study:
- To review B cell immunobiology and highlight biomaterial engineering strategies for therapeutic applications.
- To discuss advancements in B cell targeted antigen delivery, sustained antigen delivery, and antigen engineering.
- To explore methods for optimizing T cell help and B cell suppression using biomaterials.
Main Methods:
- Review of current literature on B cell biology and biomaterial engineering.
- Analysis of strategies for targeted and sustained antigen delivery.
- Discussion of T cell modulation and B cell suppression techniques within biomaterial platforms.
Main Results:
- Biomaterial platforms can facilitate immunogenic reagent trafficking and regulate T cell responses.
- Engineering approaches offer improved B cell targeted antigen delivery and sustained antigen exposure.
- Advanced biomaterials can modulate the immune microenvironment to optimize therapeutic B cell responses.
Conclusions:
- Biomaterial engineering presents significant opportunities to overcome limitations in current B cell therapies.
- Leveraging biomaterials can enhance humoral immunity for more effective and durable therapeutic outcomes.
- Future directions involve novel biomaterial designs to fully harness the potential of B cell immunity.
Related Concept Videos
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
01:40Cell-mediated Immune Responses
68.3K
Overview
68.3K
01:31Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
01:20Special Features of Adaptive Immunity
816
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
816